Search results
Results From The WOW.Com Content Network
DEA lawsuit NO. 20-71433, the Ninth Circuit dismissed a petition that asked the court to review the DEA's denial of a letter that requested the agency reschedule marijuana. Under the CSA, the DEA must begin investigating the rescheduling of a drug after receiving a petition by from any interested party, including the manufacturer of a drug, a ...
A Drug Enforcement Administration (DEA) judge canceled an upcoming hearing on the Biden administration’s marijuana rescheduling proposal pending appeals, effectively kicking the process to the ...
In a move that could significantly impact the cannabis reform landscape, the Drug Enforcement Administration (DEA) announced a delay on Monday in the rescheduling of marijuana, noting it would ...
An administrative law judge nixed a DEA hearing on the proposed rescheduling of marijuana set to take place next week, pushing the hearing well into President-elect Donald Trump's next administration.
By rescheduling cannabis, the drug would now be studied and researched to identify concrete medical benefits, opening the door for pharmaceutical companies to get involved with the sale and ...
The Drug Enforcement Administration initiated a 2024 policy review to potentially reschedule marijuana as a Schedule III drug, amounting to "the agency's biggest policy change in more than 50 years". [4] Some hiring and retention policies in federal employment and the armed forces evolved during 2024.
The change from Schedule I to Schedule III is welcome, but removing it from the schedules altogether is the best option.
After the DEA reviews and considers the public comments, and at the conclusion of any requested hearing, the DEA will issue a final order to reschedule marijuana. (The DEA could decline to ...